Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-26-035831
Filing Date
2026-08-03
Accepted
2026-08-03 16:15:42
Documents
12
Period of Report
2026-07-30
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A form8-ka.htm   iXBRL 8-K/A 45952
  Complete submission text file 0001493152-26-035831.txt   264528

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cdt-20260730.xsd EX-101.SCH 3826
3 XBRL DEFINITION FILE cdt-20260730_def.xml EX-101.DEF 27145
4 XBRL LABEL FILE cdt-20260730_lab.xml EX-101.LAB 37541
5 XBRL PRESENTATION FILE cdt-20260730_pre.xml EX-101.PRE 25766
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-ka_htm.xml XML 6308
Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (646) 491 9132
CDT Equity Inc. (Filer) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-41245 | Film No.: 261233057
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)